112 related articles for article (PubMed ID: 23343635)
1. Injectable intratumoral hydrogel as 5-fluorouracil drug depot.
Seo HW; Kim DY; Kwon DY; Kwon JS; Jin LM; Lee B; Kim JH; Min BH; Kim MS
Biomaterials; 2013 Apr; 34(11):2748-57. PubMed ID: 23343635
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-tumor activity through combinational intratumoral injection of an in-situ injectable drug depot.
Kim DY; Kwon DY; Kwon JS; Park JH; Park SH; Oh HJ; Kim JH; Min BH; Park K; Kim MS
Biomaterials; 2016 Apr; 85():232-45. PubMed ID: 26874285
[TBL] [Abstract][Full Text] [Related]
3. In vivo efficacy of an intratumorally injected in situ-forming doxorubicin/poly(ethylene glycol)-b-polycaprolactone diblock copolymer.
Kang YM; Kim GH; Kim JI; Kim DY; Lee BN; Yoon SM; Kim JH; Kim MS
Biomaterials; 2011 Jul; 32(20):4556-64. PubMed ID: 21440935
[TBL] [Abstract][Full Text] [Related]
4. In vivo efficacy of paclitaxel-loaded injectable in situ-forming gel against subcutaneous tumor growth.
Lee JY; Kim KS; Kang YM; Kim ES; Hwang SJ; Lee HB; Min BH; Kim JH; Kim MS
Int J Pharm; 2010 Jun; 392(1-2):51-6. PubMed ID: 20298770
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of injectable implants for intratumoral delivery of 5-fluorouracil.
Chen W; Wu Z; Yang H; Guo S; Li D; Cheng L
Pharm Dev Technol; 2014 Mar; 19(2):223-31. PubMed ID: 23432601
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties and antitumor efficacy of the 5-fluorouracil loaded PEG-hydrogel.
Yi H; Cho HJ; Cho SM; Lee DG; Abd El-Aty AM; Yoon SJ; Bae GW; Nho K; Kim B; Lee CH; Kim JS; Bartlett MG; Shin HC
BMC Cancer; 2010 May; 10():211. PubMed ID: 20482808
[TBL] [Abstract][Full Text] [Related]
7. Efficient inhibition of colorectal peritoneal carcinomatosis by drug loaded micelles in thermosensitive hydrogel composites.
Gong C; Wang C; Wang Y; Wu Q; Zhang D; Luo F; Qian Z
Nanoscale; 2012 May; 4(10):3095-104. PubMed ID: 22535210
[TBL] [Abstract][Full Text] [Related]
8. A biodegradable, injectable, gel system based on MPEG-b-(PCL-ran-PLLA) diblock copolymers with an adjustable therapeutic window.
Kang YM; Lee SH; Lee JY; Son JS; Kim BS; Lee B; Chun HJ; Min BH; Kim JH; Kim MS
Biomaterials; 2010 Mar; 31(9):2453-60. PubMed ID: 20022371
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique.
Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q
Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846
[TBL] [Abstract][Full Text] [Related]
10. Drug retention and distribution after intratumoral chemotherapy with fluorouracil/epinephrine injectable gel in human pancreatic cancer xenografts.
Smith JP; Kanekal S; Patawaran MB; Chen JY; Jones RE; Orenberg EK; Yu NY
Cancer Chemother Pharmacol; 1999; 44(4):267-74. PubMed ID: 10447573
[TBL] [Abstract][Full Text] [Related]
11. Peri-tumor administration of 5-fluorouracil sol-gel using a hollow microneedle for treatment of gastric cancer.
Jung YS; Koo DH; Yang JY; Lee HY; Park JH; Park JH
Drug Deliv; 2018 Nov; 25(1):872-879. PubMed ID: 29608119
[TBL] [Abstract][Full Text] [Related]
12. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
[TBL] [Abstract][Full Text] [Related]
13. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats.
Menei P; Boisdron-Celle M; Croué A; Guy G; Benoit JP
Neurosurgery; 1996 Jul; 39(1):117-23; discussion 123-4. PubMed ID: 8805147
[TBL] [Abstract][Full Text] [Related]
14. 5-FU-hydrogel inhibits colorectal peritoneal carcinomatosis and tumor growth in mice.
Wang Y; Gong C; Yang L; Wu Q; Shi S; Shi H; Qian Z; Wei Y
BMC Cancer; 2010 Aug; 10():402. PubMed ID: 20678220
[TBL] [Abstract][Full Text] [Related]
15. Injectable and Biodegradable pH-Responsive Hydrogels for Localized and Sustained Treatment of Human Fibrosarcoma.
Li L; Gu J; Zhang J; Xie Z; Lu Y; Shen L; Dong Q; Wang Y
ACS Appl Mater Interfaces; 2015 Apr; 7(15):8033-40. PubMed ID: 25838258
[TBL] [Abstract][Full Text] [Related]
16. An injectable biodegradable temperature-responsive gel with an adjustable persistence window.
Kim JI; Kim DY; Kwon DY; Kang HJ; Kim JH; Min BH; Kim MS
Biomaterials; 2012 Apr; 33(10):2823-34. PubMed ID: 22261098
[TBL] [Abstract][Full Text] [Related]
17. Self-Assembling Monomeric Nucleoside Molecular Nanoparticles Loaded with 5-FU Enhancing Therapeutic Efficacy against Oral Cancer.
Zhao H; Feng H; Liu D; Liu J; Ji N; Chen F; Luo X; Zhou Y; Dan H; Zeng X; Li J; Sun C; Meng J; Ju X; Zhou M; Yang H; Li L; Liang X; Chu L; Jiang L; He Y; Chen Q
ACS Nano; 2015 Oct; 9(10):9638-51. PubMed ID: 26349079
[TBL] [Abstract][Full Text] [Related]
18. Effects of amphiphilic PCL-PEG-PCL copolymer addition on 5-fluorouracil release from biodegradable PCL films for stent application.
Lu F; Lei L; Shen YY; Hou JW; Chen WL; Li YG; Guo SR
Int J Pharm; 2011 Oct; 419(1-2):77-84. PubMed ID: 21803141
[TBL] [Abstract][Full Text] [Related]
19. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001.
Cunningham C; Nemunaitis J
Hum Gene Ther; 2001 Aug; 12(12):1594-6. PubMed ID: 11529249
[TBL] [Abstract][Full Text] [Related]
20. Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors.
Lin Q; Cai Y; Yuan M; Ma L; Qiu M; Su J
Oncol Rep; 2014 Dec; 32(6):2405-10. PubMed ID: 25231485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
